Drugs / OPAL A
last change Dec 2016 re-read 3 minutes ago

OPAL A

Developed for
decubitus ulcer · ulcer of lower limbs

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT00933348 Comparator Jan 2010 → Dec 2016 decubitus ulcer, ulcer of lower limbs Phoenix Eagle Company Suspended No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as OPAL A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00933348 ↗
Route Topical “Cream (about 1 to 5 g applied as a thin smear on surrounding skin)” NCT00933348 ↗